Survival after recurrent osteosarcoma: Data from 3 European Osteosarcoma Intergroup (EOI) randomized controlled trials-Reference-Cited by-同舟云学术

Survival after recurrent osteosarcoma: Data from 3 European Osteosarcoma Intergroup (EOI) randomized controlled trials

Published:2011-04 Issue:6 Volume:47 Page:895-902
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Gelderblom Hans,Jinks Rachel C.,Sydes Matthew,Bramwell Vivien H.C.,van Glabbeke Martine,Grimer Robert J.,Hogendoorn Pancras C.W.,McTiernan Anne,Lewis Ian J.,Nooij Marianne A.,Taminiau Antonie H.M.,Whelan Jeremy

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference15 articles.

1. Postrelapse survival in osteosarcoma of the extremities: prognostic factors for long-term survival;Ferrari;J Clin Oncol,2003

2. A comparison of two short intensive adjuvant chemotherapy regimens in operable osteosarcoma of limbs in children and young adults: the first study of the European Osteosarcoma Intergroup;Bramwell;J Clin Oncol,1992

3. Randomised trial of two regimens of chemotherapy in operable osteosarcoma: a study of the European Osteosarcoma Intergroup;Souhami;Lancet,1997

4. Improvement in histologic response but not survival in osteosarcoma patients treated with intensified chemotherapy: a randomized phase III trial of the European Osteosarcoma Intergroup;Lewis;J Natl Cancer Inst,2007

5. Preoperative chemotherapy for osteogenic sarcoma: selection of postoperative adjuvant chemotherapy based on the response of the primary tumor to preoperative chemotherapy;Rosen;Cancer,1982

Cited by 115 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pulmonary metastasectomy in pediatric patients: a narrative review;Video-Assisted Thoracic Surgery;2024-06

2. Reversine inhibits proliferation and induces apoptosis of human osteosarcoma cells through targeting MEK1;Journal of Bone Oncology;2024-06

3. Comprehensive analysis to identify PUS7 as a prognostic biomarker from pan-cancer analysis to osteosarcoma validation;Aging;2024-05-30

4. Novel biomarkers in bone sarcomas — diagnosis, treatment selection, and clinical trials;Oncology in Clinical Practice;2024-04-19

5. Exploring the Diagnostic Dilemma of Indeterminate Pulmonary Nodules in Patients with Primary Sarcoma of Bone;Sarcoma;2024-03-05